CHANGING PATTERN OF THE USE OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Sanchez-Piedra, Carlos [1 ]
Prior-Espanol, Agueda [2 ]
Freire Gonzalez, Mercedes [3 ]
Colazo, Maria [4 ]
Ruiz-Montesinos, Dolores [5 ]
Perez-Vera, Yanira [6 ]
Ortiz, Ana [7 ]
Bustabad, Sagrario [8 ]
Vela-Casasempere, Paloma [9 ]
Rojas-Gimenez, Marta [10 ]
Sanchez-Alonso, Fernando [1 ]
Diaz-Gonzalez, Federico [1 ]
Jesus Gomez-Reino, Juan [11 ]
机构：
[1] Spanish Soc Rhematol, Madrid, Spain
[2] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[3] Complexo Hosp Univ A Coruna, La Coruna, Spain
[4] Hosp Burgos, Burgos, Spain
[5] Hosp Virgen de la Macarena, Seville, Spain
[6] Hosp Univ Gran Canaria Doctor Negrin, Las Palmas Gran Canaria, Spain
[7] Hosp La Princesa, Madrid, Spain
[8] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain
[9] Hosp Univ Alicante, Alicante, Spain
[10] Hosp Reg Univ Malaga, Malaga, Spain
[11] Hosp Univ Santiago, Santiago De Compostela, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0159
引用
收藏
页码：1151 / 1152
页数：2
相关论文
共 50 条
  • [1] Treatment Patterns with Disease-Modifying Antirheumatic Drugs in US Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Walsh, Jessica A.
    Pei, Shaobo
    Penmetsa, Gopi K.
    Sauer, Brian C.
    Patil, Vikas
    Walker, Jodi H.
    Clewell, Jerry
    Douglas, Kevin M.
    Clegg, Daniel O.
    Cannon, Grant W.
    Halwani, Ahmad
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1218 - +
  • [2] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis
    Marguerie, L
    Flipo, RM
    Grardel, B
    Beaurain, D
    Duquesnoy, B
    Delcambre, B
    [J]. JOINT BONE SPINE, 2002, 69 (03) : 275 - 281
  • [3] COST OF TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE PERIOD 2013-2014 IN BULGARIA
    Boyadzhieva, V. L.
    Stoilov, N.
    Stoilov, R.
    Petrova, G.
    Stefanov, S.
    Medjidieva, D.
    [J]. JOURNAL OF THE BALKAN TRIBOLOGICAL ASSOCIATION, 2016, 22 (01): : 401 - 409
  • [4] Effects of the COVID-19 Pandemic in Unvaccinated Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients Using Disease-modifying Antirheumatic Drugs
    Sari, Kemal
    Ozkan, Feyza Unlu
    Aktas, Ilknur
    Akpinar, Pinar
    [J]. MEDICAL JOURNAL OF BAKIRKOY, 2023, 19 (02) : 171 - 179
  • [5] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [6] An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis
    So, Anthony
    Inman, Robert Davies
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 453 - 471
  • [7] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S110 - S110
  • [8] Predictors of effectiveness of biologic disease-modifying antirheumatic drugs (bDMARD) in the treatment of psoriatic arthritis
    Brandao, Natalia Dias
    Morgado, Marina
    Oliveira, Gerusa A.
    Acurcio, Francisco de Assis
    Guerra Junior, Augusto Afonso
    Alvares-Teodoro, Juliana
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 170 - 171
  • [9] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
    Li, Ko-Jen
    Chang, Chia-Li
    Hsin, Chih-Yi
    Tang, Chao-Hsiun
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
12345